NL7309435A - - Google Patents

Info

Publication number
NL7309435A
NL7309435A NL7309435A NL7309435A NL7309435A NL 7309435 A NL7309435 A NL 7309435A NL 7309435 A NL7309435 A NL 7309435A NL 7309435 A NL7309435 A NL 7309435A NL 7309435 A NL7309435 A NL 7309435A
Authority
NL
Netherlands
Application number
NL7309435A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7309435A publication Critical patent/NL7309435A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14Radicals substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NL7309435A 1972-07-06 1973-07-05 NL7309435A (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7224544A FR2190439B1 (en:Method) 1972-07-06 1972-07-06

Publications (1)

Publication Number Publication Date
NL7309435A true NL7309435A (en:Method) 1974-01-08

Family

ID=9101469

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7309435A NL7309435A (en:Method) 1972-07-06 1973-07-05

Country Status (16)

Country Link
US (1) US3862177A (en:Method)
JP (1) JPS5434754B2 (en:Method)
AU (1) AU470009B2 (en:Method)
BE (1) BE801533A (en:Method)
CA (1) CA1001623A (en:Method)
CH (1) CH568313A5 (en:Method)
DE (1) DE2333831C3 (en:Method)
ES (1) ES416614A1 (en:Method)
FR (1) FR2190439B1 (en:Method)
GB (1) GB1374406A (en:Method)
IT (1) IT1055533B (en:Method)
LU (1) LU67903A1 (en:Method)
NL (1) NL7309435A (en:Method)
SE (1) SE403289B (en:Method)
SU (1) SU480217A3 (en:Method)
ZA (1) ZA734460B (en:Method)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2291755A2 (fr) * 1974-11-21 1976-06-18 Delalande Sa Nouveaux benzoyl-2' eth-1' yl)-1 (cinnamyl-4'' piperazin-1'' yl methyl)-2 benzimidazoles, leur procede de preparation et leur application en therapeutique
FR2297045A1 (fr) * 1975-01-10 1976-08-06 Delalande Sa Nouveaux (aroyl-2' eth-1' yl)-1 (acetamido-4'' piperazin-1'' yl methyl)-2 benzimidazoles a proprietes antisecretoire gastrique et antiulcereuse
GB1487128A (en) * 1975-01-10 1977-09-28 Delalande Sa 1-(2'-aroyl ethyl)2-(4"-carbamoyl-methyl-piperazin-1"-yl methyl)benzimidazoles their therapeutical applications and method for their preparation
JPS5540576Y2 (en:Method) * 1976-01-30 1980-09-22
JPS5640032Y2 (en:Method) * 1976-12-20 1981-09-18

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1440565A (fr) * 1964-07-23 1966-05-27 Schering Ag Nouveaux benzimidazoles substitués et leur préparation
US3362956A (en) * 1965-08-19 1968-01-09 Sterling Drug Inc 1-[(heterocyclyl)-lower-alkyl]-4-substituted-piperazines

Also Published As

Publication number Publication date
US3862177A (en) 1975-01-21
DE2333831C3 (de) 1979-04-26
DE2333831B2 (de) 1978-07-27
JPS5434754B2 (en:Method) 1979-10-29
DE2333831A1 (de) 1974-01-17
ZA734460B (en) 1974-06-26
JPS4942684A (en:Method) 1974-04-22
SE403289B (sv) 1978-08-07
LU67903A1 (en:Method) 1974-01-04
IT1055533B (it) 1982-01-11
CH568313A5 (en:Method) 1975-10-31
CA1001623A (en) 1976-12-14
ES416614A1 (es) 1976-02-01
AU5775373A (en) 1975-01-09
FR2190439B1 (en:Method) 1975-06-20
SU480217A3 (ru) 1975-08-05
FR2190439A1 (en:Method) 1974-02-01
GB1374406A (en) 1974-11-20
BE801533A (fr) 1973-12-27
AU470009B2 (en) 1976-02-26

Similar Documents

Publication Publication Date Title
HU167266B (en:Method)
FR2185781B1 (en:Method)
JPS4919533A (en:Method)
FR2190439B1 (en:Method)
JPS5714993B2 (en:Method)
JPS4932665U (en:Method)
FR2175644A1 (en:Method)
JPS5135006B2 (en:Method)
JPS4919926A (en:Method)
JPS5316153Y2 (en:Method)
JPS5237019Y2 (en:Method)
JPS5327355Y2 (en:Method)
FR2205591B3 (en:Method)
JPS49104590U (en:Method)
CH567838A5 (en:Method)
CH565318A5 (en:Method)
PL77479B1 (en:Method)
PL79733B1 (en:Method)
CH565303A5 (en:Method)
CH564423A5 (en:Method)
CH567732A5 (en:Method)
CH567504A5 (en:Method)
CH566843A5 (en:Method)
CH566729A5 (en:Method)
CH565857A5 (en:Method)

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BV The patent application has lapsed